Print

Purpose

This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years of age and older - Ability to understand study assessments and give informed consent to data collection - Ability to comply with the study protocol - Ability to understand and respond to instructions in English - Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but not limited to: HF, AS, HCM, HTN, DCM, etc. - Resides in the United States

Exclusion Criteria

  • Allergy to adhesive used in biosensor patch - Life threatening disease process outside of area under study, such as actively treated cancer or pre/post-transplant such as hepatic failure; end-stage renal disease. - Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV - Self-reported weight of 400 pounds or greater

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Cardiovascular Disease (CVD) Participants who have been diagnosed including but not limited to the following Cardiovascular Disease types: Aortic Stenosis, Heart Failure, Hypertension Obstructive Cardiomyopathy, Dilated Cardiomyopathy

Recruiting Locations

Prolaio
Chicago 4887398, Illinois 4896861 60606

More Details

Status
Recruiting
Sponsor
Prolaio

Study Contact

Study Team OCORO Study
1-855-869-9054
OCOROstudy@prolaio.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.